Pathology

Disease

Coronavirus disease 2019 (COVID-19)

Economic growth

Family medicine

Infectious disease (medical specialty)

Pandemic

Outbreak

Political science

Health care

Economics

Teledermatology

Legislation

MEDLINE

2019-20 coronavirus outbreak

Telemedicine

Medical emergency

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Medicine

International Journal of Clinical Practice

The enormous spread of the novel Corona virus disease (COVID-19) represents a challenge to dermatological practice. Accumulating evidence has suggested a possible role of teledermatology in facing this challenge. In this article, we aimed to give a general overview of teledermatology in terms of models of practice, modes of delivery, advantages, limitations, ethical considerations and legislative challenges as well as discussing, using examples from literature, how dermatological practice can benefit from teledermatology during the time of the COVID-19 pandemic.Teledermatology could be an accessible, accurate and cost-effective substitute for conventional face-to-face dermatological consultations during the COVID-19 pandemic. However, teledermatology practice needs updated legislation and guidelines. More efforts should be done to encourage dermatologists, especially in underserved communities, to provide teledermatology services. Ethical issues and data security related to teledermatology have to be considered.

Teledermatology in the time of COVID‐19